Telecom Lead Asia: Fujitsu has been selected by the
National Institute of Allergy and Infectious Diseases (NIAID), part of the
National Institutes of Health, to build a multi-node regional fiber optic
network.
The network allows researchers to access and share data
residing in remote datacenters.
Fujitsu’s FLASHWAVE 7420 Metro/Enterprise WDM Platform,
NETSMART 1500 Management System and professional services will ensure the
agency to benefit from tunable bandwidths reaching 40Gb per second performance;
sub-microsecond latency; multi-protocol, multi-application support; remote
monitoring and management; and valuable training.
Our work with NIAID is a prime example. We are working
side-by-side to architect the network, implement the technology – both hardware
and software – and train staff. Our commitment is to ensure NIAID’s fiber optic
infrastructure fully supports the critical work being done there,”said Paul
Fagan, senior vice president of sales at Fujitsu Network Communications.
Fujitsu’s FLASHWAVE 7420 is a scalable DWDM-based transport
solution engineered for high-performance, low-latency networks. The platform
includes Reconfigurable Optical Add/Drop Multiplexer (ROADM) technology. It
supports Ethernet, SONET/SDH, G.709 OTN, ATM, video and SAN protocols in fixed
and reconfigurable point-to-point, linear add/drop and ring topologies.
The Fujitsu NETSMART 1500 carrier-class management system
allows NIAID to remotely monitor, manage, provision and maintain the FLASHWAVE
7420. The solution facilitates network reliability and visibility through
performance data tracking and graphing, bandwidth capacity reports and
instantaneous alarm reports, as well as real-time fault isolation and
resolution.
In addition to planning and deploying hardware and
software, Fujitsu professional services will provide NIAID staff with training
on application and equipment engineering, turn-up, operations and maintenance.
